Articulos Recientes
https://mielomamultiple.org/wp-content/uploads/2019/03/shutterstock_1198434730-relapse-600x474.jpeg
474
600
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2019-03-25 22:10:312019-03-25 22:10:34¿Qué es el mieloma reincidente y el mieloma refractario?
https://mielomamultiple.org/wp-content/uploads/2019/03/walking-1900x1500-IMG_1142-600x474.jpg
474
600
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2019-03-25 22:00:472019-03-25 22:00:49La crisis de los opioides y sus víctimas inesperadas
https://mielomamultiple.org/wp-content/uploads/2019/03/shutterstock_760148188-compressor.jpg
1500
1900
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2019-03-13 02:04:212019-03-13 02:04:23Patient Power: ¿Qué tan agresivo debe ser el tratamiento del mieloma latente?
https://mielomamultiple.org/wp-content/uploads/2019/03/shutterstock_750661480-compressor.jpg
1500
1900
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2019-03-13 01:59:562019-03-13 01:59:58Patient Power: Consejos para pacientes con diagnóstico reciente de mieloma
https://mielomamultiple.org/wp-content/uploads/2019/02/shutterstock_751607611-590x466-2.jpg
466
590
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2019-02-15 00:47:442019-02-15 00:47:46Mayor riesgo de MGUS en familiares inmediatos con mieloma múltiple
https://mielomamultiple.org/wp-content/uploads/2018/12/shutterstock_601718768.jpg
1500
1900
Erika Johnson
http://mielomamultiple.org/wp-content/uploads/2016/04/Myeloma-Crowd-Enfold-Logo-340x156-300x138.jpg
Erika Johnson2018-12-18 06:31:432018-12-18 06:31:46Confirmando lo evidente: tener una cobertura de seguro de medicamentos mejora los resultados para los pacientes con mieloma de Medicare